Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Journal of Virology|November 13, 2015
Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus MacaquesMarissa Herrman, Janine Mühe, Carol Quink, et al.Journal for Immunotherapy of Cancer|December 17, 2021
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinomaAmani Makkouk, Xue Cher Yang, Taylor Barca, et al.Clinical & Translational Immunology|February 9, 2022
Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma modelsKevin P Nishimoto, Taylor Barca, Aruna Azameera, et al.Journal for Immunotherapy of Cancer|July 1, 2025
ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignanciesKevin P Nishimoto, Gauri Lamture, Yvan Chanthery, et al.Pageof 1